Therapeutic effects of STAT3 decoy oligodeoxynucleotide on human lung cancer in xenograft mice
- PMID: 17683579
- PMCID: PMC1988829
- DOI: 10.1186/1471-2407-7-149
Therapeutic effects of STAT3 decoy oligodeoxynucleotide on human lung cancer in xenograft mice
Abstract
Background: Signal transducer and activator of transcription 3 (STAT3) is usually constitutively activated in a variety of malignancies. Therefore, STAT3 may be a promising target for treatment of tumor cells. To explore the possibility of a double-stranded decoy oligodeoxynucleotide (ODN) targeted blocking STAT3 over-activated tumor cells, we, here, evaluate the efficacy of STAT3 decoy ODN on human lung cancer cells in vitro and in vivo.
Methods: A STAT3 decoy ODN was transfected into A549 lung cancer cell line in vitro by using lipofectamine. The flow cytometry and fluorescent microscopy were used to detect the transfection efficiency and the sub-cellular localization of STAT3 decoy ODN in A549 cells. Cell proliferation was determined by counting cell numbers and [3H]-thymidine uptake. Cell apoptosis was examined with Annexin V and propidum iodide by flow cytometry. The expression levels of STAT3 target genes were identified by RT-PCR and immunoblot. For in vivo experiment, A549 lung carcinoma-nude mice xenograft was used as a model to examine the effect of the STAT3 decoy by intratumoral injection. At the end of treatment, TUNEL and immunohistochemistry were used to examine the apoptosis and the expression levels of bcl-xl and cyclin D1 in tumor tissues.
Results: STAT3 decoy ODN was effectively transfected into A549 lung cancer cells and mainly located in nucleus. STAT3-decoy ODN significantly induced apoptosis and reduced [3H]-thymidine incorporation of A549 cells as well as down-regulated STAT3-target genes in vitro. STAT3 decoy ODN also dramatically inhibited the lung tumor growth in xenografted nude mice and decreased gene expression of bcl-xl and cyclin D1.
Conclusion: STAT3 decoy ODN significantly suppressed lung cancer cells in vitro and in vivo, indicating that STAT3 decoy ODN may be a potential therapeutic approach for treatment of lung cancer.
Figures





Similar articles
-
STAT3-decoy oligodeoxynucleotide inhibits the growth of human lung cancer via down-regulating its target genes.Oncol Rep. 2007 Jun;17(6):1377-82. Oncol Rep. 2007. PMID: 17487394
-
Inhibitory effects of decoy-ODN targeting activated STAT3 on human glioma growth in vivo.In Vivo. 2009 Mar-Apr;23(2):237-43. In Vivo. 2009. PMID: 19414409
-
Antiapoptotic activity of autocrine interleukin-22 and therapeutic effects of interleukin-22-small interfering RNA on human lung cancer xenografts.Clin Cancer Res. 2008 Oct 15;14(20):6432-9. doi: 10.1158/1078-0432.CCR-07-4401. Clin Cancer Res. 2008. PMID: 18927282
-
Targeting signal-transducer-and-activator-of-transcription-3 for prevention and therapy of cancer: modern target but ancient solution.Ann N Y Acad Sci. 2006 Dec;1091:151-69. doi: 10.1196/annals.1378.063. Ann N Y Acad Sci. 2006. PMID: 17341611 Review.
-
Signal transducer and activator of transcription 3 (Stat3) in epithelial carcinogenesis.Mol Carcinog. 2007 Aug;46(8):725-31. doi: 10.1002/mc.20342. Mol Carcinog. 2007. PMID: 17610223 Review.
Cited by
-
Transcription factor decoy: a pre-transcriptional approach for gene downregulation purpose in cancer.Tumour Biol. 2015 Jul;36(7):4871-81. doi: 10.1007/s13277-015-3344-z. Epub 2015 Apr 4. Tumour Biol. 2015. PMID: 25835969 Review.
-
Blockage of the STAT3 signaling pathway with a decoy oligonucleotide suppresses growth of human malignant glioma cells.J Neurooncol. 2008 Aug;89(1):9-17. doi: 10.1007/s11060-008-9590-9. Epub 2008 Apr 16. J Neurooncol. 2008. PMID: 18415045
-
Lack of toxicity of a STAT3 decoy oligonucleotide.Cancer Chemother Pharmacol. 2009 May;63(6):983-95. doi: 10.1007/s00280-008-0823-6. Epub 2008 Sep 3. Cancer Chemother Pharmacol. 2009. PMID: 18766340 Free PMC article.
-
Applications and advancements of nanoparticle-based drug delivery in alleviating lung cancer and chronic obstructive pulmonary disease.Naunyn Schmiedebergs Arch Pharmacol. 2024 May;397(5):2793-2833. doi: 10.1007/s00210-023-02830-w. Epub 2023 Nov 22. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 37991539 Review.
-
Deactivation of signal transducer and activator of transcription 3 reverses chemotherapeutics resistance of leukemia cells via down-regulating P-gp.PLoS One. 2011;6(6):e20965. doi: 10.1371/journal.pone.0020965. Epub 2011 Jun 6. PLoS One. 2011. PMID: 21677772 Free PMC article.
References
-
- Yu H, Jove R. The STATs of cancer-new molecular targets come of age. Nat Rev Cancer. 2004;4:97–105. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous